Equities

Nova Leap Health Corp

NLH:CVE

Nova Leap Health Corp

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (CAD)0.24
  • Today's Change0.00 / 0.00%
  • Shares traded2.80k
  • 1 Year change+33.33%
  • Beta1.5307
Data delayed at least 15 minutes, as of Sep 19 2024 18:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nova Leap Health Corp. is a Canada-based acquisitive home health care services company operating in the United States (U.S.) and Canada. The Company, through its subsidiaries, provides various services to clients and families, including dementia care, companionship, personal care, respite care, cooking and meal preparation, light housekeeping, activities of daily living (ADL), transportation services, medication reminders, and medication administration by nursing staff. Its supportive services can be arranged for any frequency of time, from one to twenty-four hours of care daily, or on a respite or temporary basis. The Company's services can be funded through a variety of sources, including Medicaid waiver programs, long-term care insurance, veterans benefits, private pay and other location-specific social service programs. It operates in approximately eight different U.S. states within the New England, Southeastern, South-Central and Midwest regions as well as Nova Scotia, Canada.

  • Revenue in CAD (TTM)35.08m
  • Net income in CAD170.51k
  • Incorporated2015
  • Employees--
  • Location
    Nova Leap Health Corp7071 Bayers Road, Suite 3006HALIFAX B3L 2C2CanadaCAN
  • Phone+1 (902) 401-9480
  • Fax+1 (902) 446-2001
  • Websitehttps://novaleaphealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Universal Ibogaine Inc2.33m-1.56m4.57m----2.80--1.96-0.0067-0.00670.01090.00540.4169--13.21---27.90---35.00--28.28---66.93-----6.550.64---3.81--77.23------
Field Trip Health & Wellness Ltd7.01m-40.92m4.65m--------0.6627-0.4955-0.49550.08210.0237-----------------57.81---583.82-----55.900.9325--405.79---124.07------
Leveljump Healthcare Corp14.90m-2.09m4.82m----1.04--0.3238-0.0223-0.02230.15580.04790.8772--12.10---12.33---16.28--13.43---14.06-----0.17810.7034--36.35---1,293.51------
NeuPath Health Inc69.26m-74.00k10.15m156.00--0.46064.050.1466-0.0014-0.00141.230.39081.62--9.00443,967.900.014-8.270.0191-12.0219.0418.790.0087-6.30--1.020.3477--5.5010.4897.42---9.30--
ARCpoint Inc9.09m-9.73m16.40m--------1.80-0.1065-0.10650.0989-0.40490.798968.006.34---87.74---386.76--32.39---109.82--0.2397-12.55-----38.73---7.74------
Nova Leap Health Corp35.08m170.51k20.64m--135.710.829918.820.58850.00180.00180.40290.28821.19--16.20--0.58010.07140.64570.092538.4035.040.4860.0641----0.0640.00-7.1820.37-26.20--7.58--
Lifespeak Inc50.67m-23.50m30.16m151.00--1.71--0.5952-0.4547-0.45470.95050.29850.4003--7.10335,566.30-18.57---79.99--89.7489.96-46.38-71.85---0.91470.8213--10.6350.8945.19------
Data as of Sep 19 2024. Currency figures normalised to Nova Leap Health Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.